반응식
[Cl:1][C:2]1[C:3]2[N:4]([C:8]([N:11]3[CH2:16][CH2:15][N:14]4[C:17]([C:20]([F:23])([F:22])[F:21])=[N:18][N:19]=[C:13]4[CH2:12]3)=[N:9][CH:10]=2)[CH:5]=[CH:6][N:7]=1.CN(C=O)C.[Br:29]N1C(=O)CCC1=O>C(OCC)(=O)C>[Br:29][C:10]1[N:9]=[C:8]([N:11]2[CH2:16][CH2:15][N:14]3[C:17]([C:20]([F:23])([F:21])[F:22])=[N:18][N:19]=[C:13]3[CH2:12]2)[N:4]2[CH:5]=[CH:6][N:7]=[C:2]([Cl:1])[C:3]=12참가 물질
반응물 3
생성물 1
시약·촉매·용매 1
실험 절차
To a 100 ml one neck round bottom flask was charged with 7-(8-chloroimidazo[1,5-a]pyrazin-3-yl)-3-(trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine (540 mg, 1.571 mmol) along with DMF (5 ml). The mixture was stirred and 1-bromopyrrolidine-2,5-dione (308 mg, 1.728 mmol) was added in on batch. The resulting reaction mixture was then stirred at room temperature for 18 hrs overnight. The mixture was diluted with ethyl acetate and washed with NaHCO3 (sat), water, dried over MgSO4, filtered and concentrated. The residue was purified by MPLC (24 g silica gel, 50% to 100% ethyl acetate in hexanes, 18 CV) to afford light color solid product 7-(1-bromo-8-chloroimidazo[1,5-a]pyrazin-3-yl)-3-(trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine (595 mg, 1.408 mmol, 90% yield). LC-MS: C12H8BrClF3N7, 421. found 422.02 [M+H]+, RT=1.30 min.
후처리
- customThe resulting reaction mixture
- stirringwas then stirred at room temperature for 18 hrs overnight
- washwashed with NaHCO3 (sat), water
- dry with materialdried over MgSO4
- filtrationfiltered
- concentrationconcentrated
- customThe residue was purified by MPLC (24 g silica gel, 50% to 100% ethyl acetate in hexanes, 18 CV)
출처 및 근거
- ORD 기록
- ord-444e34bae86449a4b117386bfc52fdce
- 출처 데이터셋
- uspto-grants-2016_09
- 특허 번호
- US09446130B2
연결된 노트
불러오는 중…